Protecting a blockbuster diabetes treatment for AstraZeneca
AstraZeneca AB
Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini
Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.
No confusion in trademark victory on summary judgment for the American Retirement Association
American Retirement Association
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Finnegan secures favorable ITC ruling related to innovative electric SUVs for BMW
BMW of North America, LLC and Bayerische Motoren Werke AG
Finnegan fights for Sony’s “exceedingly famous” mark
Sony Group Corporation
Experience
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Experience
Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement
Eisai Co., Ltd.
Experience
Nippon Shinyaku Co., Ltd. v. Sarepta Therapeutics, Inc. Nippon Shinyaku Co., Ltd. v. Sarepta Therapeutics, Inc.
1:21-cv-01015, D. Del., Judges Hall, Williams
Experience
BCL-2 inhibitors licensing agreement for Fochon Pharmaceuticals, Ltd. BCL-2 inhibitors licensing agreement for Fochon Pharmaceuticals, Ltd.
Fochon Pharmaceuticals, Ltd.
Experience
Global cross-licensing for specialty chemicals company Global cross-licensing for specialty chemicals company
Experience
Lipid nanoparticle licensing and collaboration agreements for Genevant Sciences Lipid nanoparticle licensing and collaboration agreements for Genevant Sciences
Genevant Sciences
Experience
Multiple settlement and license agreements for AbbVie, Inc. Multiple settlement and license agreements for AbbVie, Inc.
AbbVie, Inc.
Experience
Small molecule product development agreement for Roivant Sciences Small molecule product development agreement for Roivant Sciences
Roivant Scientists
Experience
TCL Communication Technology Holdings Ltd. v. Telefonaktiebolaget LM Ericsson TCL Communication Technology Holdings Ltd. v. Telefonaktiebolaget LM Ericsson
18-1363, -1380, -1382, -1732, Fed. Cir., Judges Newman, Chen, Hughes
TCL Communication Technology Holdings Ltd. et al.
Experience
Various global and U.S. license negotiations involving standard, semiconductor, and telecommunication patents Various global and U.S. license negotiations involving standard, semiconductor, and telecommunication patents
Experience
Koninklijke Philips N.V. et al. v. Schreder Lighting LLC, et al. Koninklijke Philips N.V. et al. v. Schreder Lighting LLC, et al.
1:14-cv-12282, D. Mass., Judge Talwani
Experience
Koninklijke Philips N.V. v. iGuzzini Lighting USA, Ltd., et al. Koninklijke Philips N.V. v. iGuzzini Lighting USA, Ltd., et al.
1:15-cv-03979, S.D.N.Y., Judge Pauley
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.